# Randomized, Open-label Phase 2 Study of Oral AZD0914 in the Treatment of Gonorrhea

> **NCT02257918** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 180 (actual)

## Conditions studied

- Gonorrhoea

## Interventions

- **DRUG:** AZD0914
- **DRUG:** Ceftriaxone

## Key facts

- **NCT ID:** NCT02257918
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11-25
- **Primary completion:** 2015-12-30
- **Final completion:** 2015-12-30
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2017-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02257918

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02257918, "Randomized, Open-label Phase 2 Study of Oral AZD0914 in the Treatment of Gonorrhea". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02257918. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*